Bristol-Myers to Take a $3B Tax Hit in Q4 2017 Post author:Sam Post published:January 7, 2018 Post category:BioPharma The expense is primarily related to taxes on unremitted offshore earnings, the company said. Source: BioSpace You Might Also Like Future Biotech Giants: 11 Life Science Entrepreneurs Under 30 February 22, 2017 Why Pharma Giant AstraZeneca PLC's Market Value Gained $3.8 Billion Last Month March 6, 2017 Auris Medical Fails Again in Phase III Trial March 13, 2018